Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 439

1.

CDK4 expression in chordoma: A potential therapeutic target.

Liu T, Shen JK, Choy E, Zhang Y, Mankin HJ, Hornicek FJ, Duan Z.

J Orthop Res. 2018 Jun;36(6):1581-1589. doi: 10.1002/jor.23819. Epub 2017 Dec 22.

PMID:
29194728
2.

Functional and oncological outcome after surgical resection of the scapula and clavicle for primary chondrosarcoma.

Nota SP, Russchen MJ, Raskin KA, Mankin HJ, Hornicek FJ, Schwab JH.

Musculoskelet Surg. 2017 Apr;101(1):67-73. doi: 10.1007/s12306-016-0437-9. Epub 2016 Nov 29.

PMID:
27900545
3.

Pharmacokinetics and tolerability of NSC23925b, a novel P-glycoprotein inhibitor: preclinical study in mice and rats.

Gao Y, Shen JK, Choy E, Zhang Z, Mankin HJ, Hornicek FJ, Duan Z.

Sci Rep. 2016 May 9;6:25659. doi: 10.1038/srep25659.

4.

Targeting EZH2-mediated methylation of H3K27 inhibits proliferation and migration of Synovial Sarcoma in vitro.

Shen JK, Cote GM, Gao Y, Choy E, Mankin HJ, Hornicek FJ, Duan Z.

Sci Rep. 2016 Apr 29;6:25239. doi: 10.1038/srep25239.

5.

Evaluation of P-glycoprotein (Pgp) expression in human osteosarcoma by high-throughput tissue microarray.

Gao Y, Liao Y, Shen JK, Feng Y, Choy E, Cote G, Harmon D, Mankin HJ, Hornicek FJ, Duan Z.

J Orthop Res. 2016 Sep;34(9):1606-12. doi: 10.1002/jor.23173. Epub 2016 Feb 2.

6.

Rhabdomyosarcoma: Advances in Molecular and Cellular Biology.

Sun X, Guo W, Shen JK, Mankin HJ, Hornicek FJ, Duan Z.

Sarcoma. 2015;2015:232010. doi: 10.1155/2015/232010. Epub 2015 Sep 1. Review.

7.

CD44 is a direct target of miR-199a-3p and contributes to aggressive progression in osteosarcoma.

Gao Y, Feng Y, Shen JK, Lin M, Choy E, Cote GM, Harmon DC, Mankin HJ, Hornicek FJ, Duan Z.

Sci Rep. 2015 Jun 16;5:11365. doi: 10.1038/srep11365.

8.

MicroRNA-155 expression is independently predictive of outcome in chordoma.

Osaka E, Kelly AD, Spentzos D, Choy E, Yang X, Shen JK, Yang P, Mankin HJ, Hornicek FJ, Duan Z.

Oncotarget. 2015 Apr 20;6(11):9125-39.

9.

Up-regulation of CD44 in the development of metastasis, recurrence and drug resistance of ovarian cancer.

Gao Y, Foster R, Yang X, Feng Y, Shen JK, Mankin HJ, Hornicek FJ, Amiji MM, Duan Z.

Oncotarget. 2015 Apr 20;6(11):9313-26.

10.

What's new in primary bone tumors.

Schwab JH, Lozano-Calderon SA, Mankin HJ, Raskin KA, Hornicek FJ.

J Bone Joint Surg Am. 2014 Dec 17;96(24):2099-104. doi: 10.2106/JBJS.N.01014. No abstract available.

PMID:
25520345
11.

Targeting CDK11 in osteosarcoma cells using the CRISPR-Cas9 system.

Feng Y, Sassi S, Shen JK, Yang X, Gao Y, Osaka E, Zhang J, Yang S, Yang C, Mankin HJ, Hornicek FJ, Duan Z.

J Orthop Res. 2015 Feb;33(2):199-207. doi: 10.1002/jor.22745. Epub 2014 Oct 27.

12.

Liposarcoma: a soft tissue tumor with many presentations.

Mankin HJ, Mankin KP, Harmon DC.

Musculoskelet Surg. 2014 Dec;98(3):171-7. doi: 10.1007/s12306-014-0332-1. Epub 2014 Jul 22. Review.

PMID:
25047632
13.

Schwannoma: a rare benign tumor of soft tissues.

Mankin HJ, Mankin KP.

Musculoskelet Surg. 2014 Aug;98(2):95-9. doi: 10.1007/s12306-014-0333-0. Epub 2014 Jun 24. Review.

PMID:
24958196
14.

MicroRNA-1 (miR-1) inhibits chordoma cell migration and invasion by targeting slug.

Osaka E, Yang X, Shen JK, Yang P, Feng Y, Mankin HJ, Hornicek FJ, Duan Z.

J Orthop Res. 2014 Aug;32(8):1075-82. doi: 10.1002/jor.22632. Epub 2014 Apr 24.

15.

What's new in primary malignant musculoskeletal tumors.

Schwab JH, Springfield DS, Raskin KA, Mankin HJ, Hornicek FJ.

J Bone Joint Surg Am. 2013 Dec 18;95(24):2240-6. doi: 10.2106/JBJS.M.01226. Review. No abstract available.

PMID:
24352776
16.

Malignant lymphoma of bone: a review of 119 patients.

Demircay E, Hornicek FJ Jr, Mankin HJ, Degroot H 3rd.

Clin Orthop Relat Res. 2013 Aug;471(8):2684-90. doi: 10.1007/s11999-013-2991-x. Epub 2013 Apr 17.

17.

Giant cell tumor of bone.

Raskin KA, Schwab JH, Mankin HJ, Springfield DS, Hornicek FJ.

J Am Acad Orthop Surg. 2013 Feb;21(2):118-26. doi: 10.5435/JAAOS-21-02-118. Review.

PMID:
23378375
18.

Pleomorphic spindle cell sarcoma (PSCS) formerly known as malignant fibrous histiocytoma (MFH): a complex malignant soft-tissue tumor.

Mankin HJ, Hornicek FJ, DeLaney TF, Harmon DC, Schiller AL.

Musculoskelet Surg. 2012 Dec;96(3):171-7. doi: 10.1007/s12306-012-0225-0. Epub 2012 Nov 7.

PMID:
23129168
19.

What's new in primary bone tumors.

Schwab JH, Springfield DS, Raskin KA, Mankin HJ, Hornicek FJ.

J Bone Joint Surg Am. 2012 Oct 17;94(20):1913-9. doi: 10.2106/JBJS.L.00955. Review. No abstract available.

PMID:
23079883
20.

Establishment and characterization of a novel chordoma cell line: CH22.

Liu X, Nielsen GP, Rosenberg AE, Waterman PR, Yang W, Choy E, Sassi S, Yang S, Harmon DC, Yang C, Schwab JH, Kobayashi E, Mankin HJ, Xavier R, Weissleder R, Duan Z, Hornicek FJ.

J Orthop Res. 2012 Oct;30(10):1666-73. doi: 10.1002/jor.22113. Epub 2012 Apr 13.

Supplemental Content

Loading ...
Support Center